| Literature DB >> 35223714 |
Jing-Hong Liang1, Yi-Can Chen1, Yu Zhao1, Aerziguli Kakaer1, Nan Jiang1, Shan Huang1, Shu-Xin Zhang1, Ya-Jun Chen1.
Abstract
BACKGROUND: Visual impairment (VI) is a growing public health concern among students as a result of the COVID-19 pandemic.Entities:
Keywords: COVID-19 pandemic; public health; students; successive cross-sectional study; visual impairment
Year: 2022 PMID: 35223714 PMCID: PMC8875203 DOI: 10.3389/fped.2021.813856
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Prevalence of VI before and during COVID-19 pandemic among school-aged students stratified by sociodemographic factors.
|
|
|
|
| |
|---|---|---|---|---|
|
|
| |||
| Gender | Boys | 50,730/106,664 (47.56) | 86,924/178,526 (48.69) | <0.001 |
| girls | 51,818/93,343 (55.51) | 86,318/153,100 (56.38) | ||
| Age | Children | 58,593/141,854 (41.31) | 97,698/231,024 (42.29) | <0.001 |
| Adolescents | 43,955/58,153 (75.59) | 75,544/100,602 (75.09) | ||
| Grade | Primary-school | 45,127/115,032 (39.23) | 83,577/207,443 (40.29) | <0.001 |
| Secondary-school | 27,786/41,699 (66.63) | 57,351/84,582 (67.81) | ||
| High-school | 19,313/23,649 (81.67) | 32,314/39,601 (81.60) | ||
| Socioeconomic statues (monthly income/RMB) | <5,000 | 40,351/80,889 (49.88) | 69,166/136,327 (50.74) | <0.001 |
| 5,000–7,999 | 21,579/41,574 (51.91) | 36,372/68,984 (52.73) | ||
| 8,000–11,999 | 13,320/25,047 (53.18) | 22,271/40,980 (54.35) | ||
| ≥12,000 | 27,297/52,495 (52.00) | 27,986/51,955 (53.87) | ||
| Parental myopia | Yes | 47,963/102,404 (46.84) | 80,875/169,308 (47.77) | 0.653 |
| No | 54,584/97,601 (55.93) | 92,367/162,318 (56.90) | ||
| Total Outdoor time, h/d | T <1 | 43,580/82,625 (52.74) | 78,086/147,247 (53.03) | <0.001 |
| 1 ≤ T <2 | 42,764/84,612 (50.54) | 70,510/135,906 (51.88) | ||
| T≥2 | 16,203/32,768 (49.45) | 24,645/48,472 (50.84) | ||
| Sunshine-related outdoor time, h/d | T <1 | 34,788/66,114 (52.62) | 64,472/121,679 (52.99) | <0.001 |
| 1 ≤ T <2 | 44,166/86,514 (51.05) | 72,753/139,646 (52.10) | ||
| T≥2 | 23,593/47,377 (49.80) | 36,016/70,300 (51.23) | ||
| Total Screen-based time, h/d | T <1 | 60,464/122,962 (49.17) | 97,227/197,373 (49.26) | <0.001 |
| 1 ≤ T <2 | 26,378/50,705 (52.02) | 46,087/86,803 (53.09) | ||
| 2 ≤ T <3 | 7,811/12,924 (60.44) | 16,656/27,168 (61.31) | ||
| 3 ≤ T <4 | 2,788/4,251 (65.58) | 6,239/9,473 (65.86) | ||
| T≥4 | 2,336/3,603 (64.83) | 6,436/9,665 (66.59) | ||
| Study-related screen-based time, h/d | T <1 | 3,617/7,084 (51.06) | 7,461/14,420 (51.74) | <0.001 |
| 1 ≤ T <2 | 24,178/53,294 (45.37) | 41,762/88,627 (47.12) | ||
| 2 ≤ T <3 | 37,343/75,448 (49.50) | 62,211/122,683 (50.71) | ||
| 3 ≤ T <4 | 24,496/43,217 (56.68) | 40,686/71,692 (56.75) | ||
| T≥4 | 11,686/18,575 (62.91) | 20,440/32,870 (62.18) | ||
| Entertainment-related screen-based time, h/d | T <1 | NA | 130,917/254,462 (51.45) | NA |
| 1 ≤ T <2 | NA | 29,109/54,401 (53.51) | ||
| 2 ≤ T <3 | NA | 7,359/12,289 (59.88) | ||
| 3 ≤ T <4 | NA | 2,218/3,670 (60.44) | ||
| T≥4 | NA | 1,222/2,057 (59.41) | ||
NO, Number; RMB, Renminbi (Yuan); T, Time; VI, Visual impairment.
Prevalence of VI before and during COVID-pandemic among students aged 6 to 18 years.
|
|
|
| |||||
|---|---|---|---|---|---|---|---|
|
|
| ||||||
|
|
|
|
|
|
| ||
| 6 | 47 | 10 (43.48) | 13 (56.52) | 1,110 | 272 (50.09) | 271 (49.91) | 0.9982 |
| 7 | 61,252 | 11,321 (51.22) | 10,782 (48.78) | 28,220 | 5,301 (53.02) | 4,698 (46.98) | 0.0584 |
| 8 | 64,816 | 10,893 (51.75) | 10,157 (48.25) | 58,035 | 10,041 (53.61) | 8,690 (46.39) | 0.4518 |
| 9 | 60,685 | 10,842 (51.39) | 10,254 (48.61) | 58,194 | 10,662 (52.91) | 9,489 (47.09) | 0.6228 |
| 10 | 57,635 | 12,000 (49.77) | 12,109 (50.23) | 53,932 | 11,443 (51.50) | 10,775 (48.50) | 0.0317 |
| 11 | 56,761 | 13,950 (48.80) | 14,636 (51.20) | 50,050 | 12,274 (49.85) | 12,348 (50.15) | 0.0001 |
| 12 | 51,597 | 14,809 (49.36) | 15,193 (50.64) | 49,295 | 14,122 (49.44) | 14,444 (50.56) | 0.5247 |
| 13 | 44,068 | 14,572 (49.74) | 14,722 (50.26) | 46,363 | 15,302 (50.50) | 14,999 (49.50) | 0.0004 |
| 14 | 40,810 | 14,740 (49.84) | 14,834 (50.16) | 39,449 | 14,359 (50.67) | 13,981 (49.33) | 0.0472 |
| 15 | 38,095 | 14,932 (51.52) | 14,051 (48.48) | 39,000 | 15,190 (50.86) | 14,679 (49.14) | 0.0982 |
| 16 | 28,969 | 11,341 (49.26) | 11,682 (50.74) | 31,391 | 12,517 (50.80) | 12,123 (49.20) | 0.0031 |
| 17 | 26,644 | 10,702 (49.47) | 10,930 (50.53) | 24,137 | 9,590 (49.64) | 9,729 (50.36) | 0.0011 |
| 18 | 16,485 | 6,746 (49.87) | 6,780 (50.13) | 18,195 | 7,504 (51.78) | 6,987 (48.22) | 0.0000 |
| Total | 547,864 | 146,858 (50.12) | 146,143 (49.88) | 497,371 | 138,577 (50.99) | 133,213 (49.01) | 0.0000 |
NO, Number; VI, Visual impairment.
Prevalence of VI before and during COVID-pandemic among students aged 6 to 18 years.
CI, Confidence interval; NO, Number; VI, Visual impairment.
Figure 1Prevalence of VI before and during COVID-pandemic among students aged 6 to 18 years. VI, Visual impairment.
Figure 2Prevalence of mild to severe VI before and during COVID-pandemic among school-aged students. NO, Number; PPY, Prevalence per year; VI, Visual impairment.